Gene Alterations Linked to Poor Outcomes in A Pediatric Cancer A survey of the neuroblastoma cancer genome revealed alterations in two genes, ARID1A and ARID1B, associated with a poor prognosis.
Not exact matches
About 10 to 15 percent of people with autism have a disorder
linked to a known single -
gene mutation, such as fragile X syndrome, or chromosomal
alterations.
Learning more about how synapses change their connections could help scientists better understand neurodevelopmental disorders such as autism, since many of the genetic
alterations linked to autism are found in
genes that code for synaptic proteins.
An
alteration in the neuregulin - 1
gene — a single change in one letter of the DNA code for the protein — has been found in families with schizophrenia and
linked to late - onset Alzheimer's disease with psychosis.
Some of the common genetic
alterations identified in the study were gains and losses in chromosome 8, as well as cell proliferation and cell - cycle progression — key mechanisms of cancer caused by genetic
alterations —
linked to the
genes AURKA, AURKB and FOXM1.
None of the modified
genes has a direct
link to cancer, however, making it unclear whether these chemical
alterations increase the risk of developing the disease.
In 1989, Vogelstein's identification of p53
gene mutations in colon cancer began a tide of research
linking alterations in the
gene to other cancers.
Forms of variation include single DNA base pair
alterations, duplications or deletions of
genes or sets of
genes, and translocations, a chromosomal rearrangement in which a segment of genetic material from one chromosome becomes heritably
linked to another chromosome.
In addition, the mutations in ARID1A provide an important new
link between genetic and epigenetic (
alterations to the environment of
genes) mechanisms in human cancer.
Because the pathophysiology of cancer is
linked to
alteration of cellular
gene expression, the bioinformatics toolbox promises to offer countless molecular insights into mechanisms, diagnostics, and new medical interventions for cancer.